Company Filing History:
Years Active: 2007
Title: Innovations of Shin-ichi Mochizuki
Introduction
Shin-ichi Mochizuki is a notable inventor based in Tochigi, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of novel proteins with potential pharmaceutical applications. His work focuses on addressing obesity and related health issues through innovative protein research.
Latest Patents
Mochizuki holds a patent for a novel protein and processes for producing the same. The patent describes a glycoprotein that suppresses the differentiation and maturation of adipocytes. This protein has a molecular weight of approximately 45 kD under non-reducing conditions and about 28 kD and/or 23 kD under reducing conditions. It exhibits affinity to heparin, making it a valuable candidate for pharmaceutical compositions aimed at preventing or treating obesity. The process for producing this protein involves culturing human fibroblasts and purifying the culture broth through various chromatography techniques. Additionally, a cDNA encoding the protein and a method for producing the protein using the cDNA are included in the patent.
Career Highlights
Shin-ichi Mochizuki is associated with Daiichi Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has the potential to impact the pharmaceutical industry significantly, particularly in the area of obesity treatment.
Collaborations
Mochizuki has collaborated with notable colleagues, including Masaaki Goto and Akihiro Tomoyasu. Their combined expertise contributes to the innovative research and development efforts at Daiichi Pharmaceutical Co., Ltd.
Conclusion
Shin-ichi Mochizuki's contributions to biotechnology and his innovative patent for a novel protein highlight his role as a significant inventor in the field. His work not only addresses critical health issues but also paves the way for future advancements in pharmaceutical applications.